Clinical Research Directory
Browse clinical research sites, groups, and studies.
Normalizing Antibody Detection in First-void Urine
Sponsor: Universiteit Antwerpen
Summary
The aim of this study is to develop robust analytical protocols for the monitoring of vaccine induced immunity against the Human Papillomavirus (HPV) in first-void urine samples and to examine fluctuations of urinary HPV-specific antibodies and potential normalization markers in different cohorts.
Official title: URINORM: Normalizing Antibody Detection in First-void Urine
Key Details
Gender
All
Age Range
9 Years - 70 Years
Study Type
OBSERVATIONAL
Enrollment
150
Start Date
2023-12-07
Completion Date
2026-01-01
Last Updated
2024-09-03
Healthy Volunteers
Yes
Conditions
Interventions
Sampling
Collection of first-void urine (i.e. the initial stream of the urine) with the Colli-Pee device (Novosanis, Belgium) (6-21 samples over a period of 36 days). Collection of blood samples (2 samples, at day 1 and 36 of the study).
Locations (1)
University of Antwerp
Edegem, Antwerp, Belgium